Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System

Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System

Detalles Bibliográficos
Main Authors:	Kim, J, Kim, S, Waters, P, Vincent, A, Park, K, Sung, J, Lee, K
Formato:	Conference item
Publicado:	2012

Títulos similares

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
por: Yang, H, et al.
Publicado: (2012)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
por: Kim, J, et al.
Publicado: (2013)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
por: Park, K, et al.
Publicado: (2012)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
por: Kim, B, et al.
Publicado: (2010)

Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.
por: Kim, S, et al.
Publicado: (2014)

Autoantibodies at the neuromuscular junction - Link to the central nervous system
por: Vincent, A
Publicado: (2014)

Olfactory Pathology in Central Nervous System Demyelinating Diseases.
por: DeLuca, G, et al.
Publicado: (2014)

Psychiatric disorders in children with demyelinating diseases of the central nervous system
por: Pakpoor, J, et al.
Publicado: (2017)

New autoantibody mediated disorders of the central nervous system.
por: Lang, B, et al.
Publicado: (2003)

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
por: Waters, P, et al.
Publicado: (2019)

Autoantibodies and the nervous system
por: Vincent, A, et al.
Publicado: (2008)

Peripheral nervous system involvement in MOG antibody-associated demyelination
por: Ramanathan, S, et al.
Publicado: (2019)

Application of metabolomics in inflammatory demyelinating diseases of the central nervous system
por: Yeo, T
Publicado: (2020)

Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries
por: Huang, Aric, et al.
Publicado: (2022)

Autoantibody-mediated disorders of the central nervous system.
por: Irani, S, et al.
Publicado: (2008)

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
por: Waters, P, et al.
Publicado: (2019)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
por: Elsone, L, et al.
Publicado: (2014)

Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
por: Hacohen, Y, et al.
Publicado: (2014)

Higher fish consumption and lower risk of central nervous system demyelination
por: Black, L, et al.
Publicado: (2019)

Stressful life events and the risk of initial central nervous system demyelination
por: Saul, A, et al.
Publicado: (2017)

Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort
por: Hacohen, Y, et al.
Publicado: (2014)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Waters, P, et al.
Publicado: (2015)

Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.
por: Irani, SR, et al.
Publicado: (2014)

Central Nervous System Neuronal Surface Antibodies
por: Coutinho, E, et al.
Publicado: (2013)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
por: Min, J, et al.
Publicado: (2010)

Demyelination after anti-TNF therapy: Who is at risk?
por: Williams, I, et al.
Publicado: (2020)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
por: Sato, D, et al.
Publicado: (2014)

Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.
por: Kim, S, et al.
Publicado: (2010)

Factors associated with the AQP4-Ab positivity in patients with longitidunally extensive transverse myelitis (LETM): possible role of asymptomatic VEP abnormality
por: Kim, J, et al.
Publicado: (2013)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
por: Kezuka, T, et al.
Publicado: (2014)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
por: Jurynczyk, M, et al.
Publicado: (2016)

Anti-MOG Antibody Seropositive Patient Successfully Treated with Intermittent Rituximab Infusion
por: Kim, W, et al.
Publicado: (2014)

Reported changes in dietary behavior following a first clinical diagnosis of central nervous system demyelination
por: Russell, R, et al.
Publicado: (2018)

Ibotenic acid induced demyelination in the central nervous system: a consequence of a local inflammatory response.
por: Coffey, P, et al.
Publicado: (1988)

Higher Non-processed Red Meat Consumption Is Associated With a Reduced Risk of Central Nervous System Demyelination
por: Black, L, et al.
Publicado: (2019)

Autoimmune channelopathies: new antibody-mediated disorders of the central nervous system.
por: Vincent, A
Publicado: (2009)

Glycine receptor antibody — a marker for NMO/ NON-MS demyelination?
por: Hamid, S, et al.
Publicado: (2015)

Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
por: Rozsa, C, et al.
Publicado: (2008)

The detection of autoantibody-forming cells. II. Cells in lymph nodes and central nervous system containing antibody to myelin basic protein.
por: Lennon, V, et al.
Publicado: (1972)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, K, et al.
Publicado: (2018)